The Iron Chelator Deferoxamine Prevents Cisplatin-Induced Lipid Peroxidation in Rat Kidney Cortical Slices
Open Access
- 1 January 1991
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 57 (2) , 259-262
- https://doi.org/10.1254/jjp.57.259
Abstract
We evaluated the effect of the iron chelator deferoxamine on lipid peroxidation produced by the nephrotoxic antineoplastic drug cisplatin in rat kidney cortical slices. The addition of deferoxamine to the incubation medium prevented such lipid peroxidation in the incubated slices. Treatment of rats with deferoxamine inhibited the increase in lipid peroxidation caused by cisplatin in the medium. These results suggest that iron may be a causal agent of cisplatin-induced lipid peroxidation.Keywords
This publication has 13 references indexed in Scilit:
- Intracellular iron redistributionBiochemical Pharmacology, 1990
- Role of iron in postischemic renal injury in the ratKidney International, 1988
- Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengersToxicology, 1988
- Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammationBiochemical Journal, 1986
- Inhibitory Effect of Lithium on p-Aminohippurate Transport in Rat Kidney Cortex in vitroKidney and Blood Pressure Research, 1985
- Oxygen toxicity, oxygen radicals, transition metals and diseaseBiochemical Journal, 1984
- Iron Transport and Storage ProteinsAnnual Review of Biochemistry, 1980
- [30] Microsomal lipid peroxidationPublished by Elsevier ,1978
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959